Further milestone payment triggered post US launch
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announces that following Haleon's distribution of online pre-orders and the availability of Eroxon® in retailers in the US, the next milestone payment due under the agreement with Haleon of $5.0m has been triggered and is expected to be received by the Company shortly.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.